MANCINI, NICASIO
 Distribuzione geografica
Continente #
EU - Europa 5.323
AS - Asia 4.189
NA - Nord America 3.438
SA - Sud America 1.092
AF - Africa 104
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.159
Nazione #
US - Stati Uniti d'America 3.227
RU - Federazione Russa 2.792
SG - Singapore 1.418
CN - Cina 1.332
IT - Italia 971
BR - Brasile 891
SE - Svezia 613
HK - Hong Kong 541
VN - Vietnam 412
FR - Francia 222
DE - Germania 202
GB - Regno Unito 117
CA - Canada 110
IN - India 108
FI - Finlandia 92
BD - Bangladesh 82
AR - Argentina 77
NL - Olanda 74
MX - Messico 60
PL - Polonia 49
AT - Austria 47
JP - Giappone 43
IE - Irlanda 42
ZA - Sudafrica 42
EC - Ecuador 41
TR - Turchia 35
IQ - Iraq 34
ES - Italia 31
ID - Indonesia 30
CO - Colombia 22
SA - Arabia Saudita 21
UZ - Uzbekistan 20
PK - Pakistan 15
PY - Paraguay 14
CL - Cile 13
LT - Lituania 13
PH - Filippine 13
MA - Marocco 12
PE - Perù 12
VE - Venezuela 11
AE - Emirati Arabi Uniti 10
TN - Tunisia 10
IR - Iran 9
JM - Giamaica 9
JO - Giordania 9
MY - Malesia 9
UA - Ucraina 9
EG - Egitto 8
RO - Romania 8
AU - Australia 7
BE - Belgio 7
CR - Costa Rica 7
DZ - Algeria 7
NI - Nicaragua 7
AZ - Azerbaigian 6
KE - Kenya 6
UY - Uruguay 6
HU - Ungheria 5
KZ - Kazakistan 5
RS - Serbia 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
GA - Gabon 4
IL - Israele 4
NP - Nepal 4
AL - Albania 3
BH - Bahrain 3
CM - Camerun 3
GY - Guiana 3
HR - Croazia 3
KH - Cambogia 3
KR - Corea 3
MU - Mauritius 3
PA - Panama 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
A1 - Anonimo 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EU - Europa 2
GD - Grenada 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SN - Senegal 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
Totale 14.147
Città #
Singapore 629
Moscow 606
Dallas 553
Hong Kong 538
Ashburn 526
San Jose 358
Shanghai 291
Milan 285
Beijing 192
Hefei 187
New York 166
Ho Chi Minh City 163
Lauterbourg 162
Princeton 153
Lawrence 150
Los Angeles 103
São Paulo 90
Hanoi 84
Rome 64
Munich 59
Helsinki 58
Warsaw 45
Chennai 43
Santa Clara 43
Nuremberg 42
Orem 42
Stockholm 37
Turin 36
Florence 35
Montreal 35
Dublin 34
Tokyo 34
Johannesburg 32
Boardman 31
Brescia 31
Denver 30
London 30
Atlanta 28
Toronto 28
Bologna 27
Poplar 27
Mexico City 25
Belo Horizonte 24
Houston 24
Turku 24
Brooklyn 22
Cesano Boscone 22
Seattle 22
Guangzhou 21
Chicago 20
Frankfurt am Main 20
Rio de Janeiro 20
Vienna 20
Boston 19
Haiphong 19
Amsterdam 18
Falkenstein 18
Shenzhen 18
The Dalles 18
Tashkent 17
Campinas 15
Phoenix 15
Council Bluffs 14
Porto Alegre 14
Brasília 13
Curitiba 13
Hangzhou 13
Pune 13
Ankara 12
Catania 12
Columbus 12
Guayaquil 12
Manchester 12
Mumbai 12
Salvador 12
San Francisco 12
Tianjin 12
Washington 12
Baghdad 11
Biên Hòa 11
Da Nang 11
Sorocaba 11
Genoa 10
Guarulhos 10
Quito 10
Lappeenranta 9
Naples 9
Paris 9
Amman 8
Barnet 8
Changsha 8
Dhaka 8
Jakarta 8
Jeddah 8
Jiaxing 8
Manaus 8
Pietra Ligure 8
Querétaro 8
Riyadh 8
Bari 7
Totale 6.924
Nome #
A modified Frosch approach for posterior tibial plateau fractures: Technical note and case series 649
Beauveria bassiana Keratitis: A Case Series and Review of Literature 174
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 171
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 164
Biobanking for COVID-19 research 145
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 140
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 135
The interferon landscape along the respiratory tract impacts the severity of COVID-19 133
Answer to Photo Quiz: Scolecobasidium sp 133
A Biologically-validated HCV E1E2 Heterodimer Structural Model 130
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 130
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 128
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 127
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 127
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 127
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 123
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 122
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 121
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 120
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota 119
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultation 119
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 119
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 117
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 117
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin 116
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 114
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 111
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 111
A new case of Echovirus 11 neonatal fulminant hepatitis involving male twins in a Northern Italy Tertiary University Hospital: Insight on a possible immunological clue 107
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 107
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 106
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules 104
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 104
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 103
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 102
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement 101
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 101
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 101
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 100
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review 100
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 99
A closer look at prion strains: Characterization and important implications 99
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 99
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 99
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 98
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 98
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 96
A novel expression vector for production of epitope-tagged recombinant Fab-fragment in bacteria 95
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 94
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 93
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy 92
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 92
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 89
IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients 89
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 89
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 88
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 88
Antibiotic resistance among sexually transmitted infections: perspectives from clinical practice 87
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 86
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 84
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition 83
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 83
Characterization of two human monoclonal anti-E2/HCV antibodies for potential application in prevention and treatment of HCV infection 83
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 82
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 82
Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity 82
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 81
Genetic characterization of Klebsiella pneumoniae carbapenemase -producing Klebsiella pneumoniae isolates with different susceptibility to ceftazidime/avibactam in patients with blood-stream infections 81
Analysis of the Enteric Microbiome: First Tentative Steps Towards a Comprehensive Work-up of Prostate Cancer? 81
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 81
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 81
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 80
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 79
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 79
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 79
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 78
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients 78
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 78
Dual-Domain Reporter Approach for Multiplex Identification of Major SARS-CoV-2 Variants of Concern in a Microarray-Based Assay 78
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 76
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 76
HCV E2 core structures and mAbs: something is still missing 75
Coronaviridae and SARS-associated coronavirus strain HSR1 74
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 74
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals 74
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 74
Role and potential therapeutic use of antibodies against herpetic infections 73
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 70
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 69
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies 69
Viral Respiratory Pathogens and Lung Injury 69
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 67
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 67
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 66
Microbiological Diagnosis of Sepsis: The Confounding Effects of a “Gold Standard” 66
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 65
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 65
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 65
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 63
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System 63
Totale 10.221
Categoria #
all - tutte 83.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022142 3 7 20 29 13 7 13 9 4 10 6 21
2022/20231.082 350 259 98 15 22 127 62 65 49 7 14 14
2023/2024756 27 40 101 92 53 149 34 70 9 23 42 116
2024/20252.998 314 65 68 111 124 240 434 367 494 301 237 243
2025/20269.320 692 716 760 1.319 731 327 754 674 2.493 444 204 206
Totale 14.493